HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Autologous stem cell transplantation as adjuvant treatment vs no further therapy for poor-risk Hodgkin's disease in first complete remission after MOPP/ABVD.

AuthorsA M Carella, N Pollicardo, E Pungolino, F Frassoni, D Giordano, R Bruni, M Spriano, E Rossi
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 15 Suppl 1 Pg. 59-61 ( 1995) ISSN: 1042-8194 [Print] United States
PMID7539318 (Publication Type: Journal Article)
Chemical References
  • Bleomycin
  • Procarbazine
  • Mechlorethamine
  • Vincristine
  • Vinblastine
  • Dacarbazine
  • Doxorubicin
  • Prednisone
Topics
  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Bleomycin (administration & dosage)
  • Dacarbazine (administration & dosage)
  • Doxorubicin (administration & dosage)
  • Female
  • Follow-Up Studies
  • Hematopoietic Stem Cell Transplantation
  • Hodgkin Disease (mortality, therapy)
  • Humans
  • Male
  • Mechlorethamine (administration & dosage)
  • Middle Aged
  • Prednisone (administration & dosage)
  • Procarbazine (administration & dosage)
  • Retrospective Studies
  • Survival Rate
  • Transplantation, Autologous
  • Vinblastine
  • Vincristine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: